Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 130 | 730 | -3,990 | -2,620 | -1,820 |
| Depreciation Amortization | 80 | 50 | 1,660 | 1,250 | 840 |
| Other Working Capital | 1,490 | 80 | 3,030 | 1,690 | 4 |
| Other Operating Activity | -440 | -790 | 0 | 20 | 1,376 |
| Operating Cash Flow | $1,260 | $70 | $700 | $340 | $400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -190 | -180 | -220 | -250 | -210 |
| Other Investing Activity | -1,100 | -450 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,290 | $-630 | $-220 | $-250 | $-210 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $0 | $0 | $0 | $0 | $0 |
| Exchange Rate Effect | 60 | 10 | -10 | 30 | 40 |
| Beginning Cash Position | 1,480 | 1,480 | 1,020 | 1,020 | 1,020 |
| End Cash Position | 1,520 | 930 | 1,480 | 1,150 | 1,260 |
| Net Cash Flow | $30 | $-550 | $460 | $120 | $230 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,260 | 70 | 700 | 340 | 400 |
| Free Cash Flow | 1,260 | 70 | 700 | 340 | 400 |